Click the 'X' in the top right corner to close this window.
MoneyTreeTM: Dollar drought
August 2012
At a glance
MoneyTree: biotechnology and medical device venture capital investments
Venture capitalists invested $1.4 billion in 174 life sciences deals, continuing a decline spanning four consecutive quarters. The Biotechnology and Medical Devices industries saw investments fall 39% in dollars and 22% in number of deals during the second quarter of 2012 from the same quarter of last year, according to the MoneyTreeTM Report from PricewaterhouseCoopers (PwC) LLP and the National Venture Capital Association (NVCA) based on data provided by Thomson Reuters.
Contacts
- Mike Galper
- US healthcare payer leader
- Tel: +1 (213) 217 3301
- Robert Valletta
- US healthcare provider leader
- Tel: +1 (617) 530 4053
- Michael Swanick
- Global Leader Pharmaceuticals & life sciences
- Tel: +1 (267) 330 6060
Of further interest